Taisei Mushiroda

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

Takeshi Ozeki, Taisei Mushiroda, Amara Yowang et al. · Human Molecular Genetics · 2010 · 504 citations · Full text

Clinical Pharmacogenetics Implementation Consortium Guideline for <i>HLA</i> Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

Elizabeth J. Phillips, Chonlaphat Sukasem, Michelle Whirl‐Carrillo et al. · Clinical Pharmacology & Therapeutics · 2018 · 285 citations · Full text

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

Minoli A. Perera, Larisa H. Cavallari, Nita A. Limdi et al. · The Lancet · 2013 · 272 citations · Full text

Genome-wide Association Study, Thrombosis, Genetic Variants +10

A genome-wide association study identifies an association of a common variant in <i>TERT</i> with susceptibility to idiopathic pulmonary fibrosis

Taisei Mushiroda, Sukanya Wattanapokayakit, Atsushi Takahashi et al. · Journal of Medical Genetics · 2008 · 244 citations

Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing

Michel S Hershfield, John T. Callaghan, Wichittra Tassaneeyakul et al. · Clinical Pharmacology & Therapeutics · 2012 · 239 citations · Full text